Weiying Gu

610 total citations
44 papers, 444 citations indexed

About

Weiying Gu is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Weiying Gu has authored 44 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 17 papers in Hematology and 12 papers in Cancer Research. Recurrent topics in Weiying Gu's work include Acute Myeloid Leukemia Research (14 papers), Acute Lymphoblastic Leukemia research (8 papers) and MicroRNA in disease regulation (7 papers). Weiying Gu is often cited by papers focused on Acute Myeloid Leukemia Research (14 papers), Acute Lymphoblastic Leukemia research (8 papers) and MicroRNA in disease regulation (7 papers). Weiying Gu collaborates with scholars based in China, United States and Taiwan. Weiying Gu's co-authors include Xiaobao Xie, Weimin Dong, Yan Liu, Rong Wang, Feng Zhi, Xiang-shan Cao, Yun Ling, Yilin Yang, Zixing Chen and Guoqiang Qiu and has published in prestigious journals such as Blood, PLoS ONE and Molecules.

In The Last Decade

Weiying Gu

43 papers receiving 437 citations

Peers

Weiying Gu
Matthew F. Jones United States
Keh-Dong Shiang United States
Montreh Tavakkoli United States
Weiying Gu
Citations per year, relative to Weiying Gu Weiying Gu (= 1×) peers Jingnan Sun

Countries citing papers authored by Weiying Gu

Since Specialization
Citations

This map shows the geographic impact of Weiying Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiying Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiying Gu more than expected).

Fields of papers citing papers by Weiying Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiying Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiying Gu. The network helps show where Weiying Gu may publish in the future.

Co-authorship network of co-authors of Weiying Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Weiying Gu. A scholar is included among the top collaborators of Weiying Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiying Gu. Weiying Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cao, Yue, Peng Xu, Wei Wu, et al.. (2023). Exosomes and cancer immunotherapy: A review of recent cancer research. Frontiers in Oncology. 12. 1118101–1118101. 19 indexed citations
2.
Yang, Haonan, Yang Cao, Juan Liu, et al.. (2023). Clinical characteristics and prognostic factors of 75 cases with acquired hemophagocytic syndrome. Hematology. 28(1). 2247887–2247887. 1 indexed citations
3.
4.
Liu, Yue, Yang Cao, Xiaojun Yang, et al.. (2023). High expression of miR-107 and miR-17 predicts poor prognosis and guides treatment selection in acute myeloid leukemia. Translational Cancer Research. 12(4). 913–927. 4 indexed citations
5.
Gu, Weiying, et al.. (2021). Up-regulation of circPVT1 in T cell acute lymphoblastic leukemia promoted cell proliferation via miR-30e/DLL4 induced activating NOTCH signaling. Pathology - Research and Practice. 224. 153536–153536. 14 indexed citations
6.
Zheng, Zhuojun, Xiao Zheng, Yuandong Zhu, et al.. (2019). miR-183-5p Inhibits Occurrence and Progression of Acute Myeloid Leukemia via Targeting Erbin. Molecular Therapy. 27(3). 542–558. 20 indexed citations
7.
Wu, Wei, Yan Lin, Lili Xiang, et al.. (2016). Low-dose decitabine plus all-trans retinoic acid in patients with myeloid neoplasms ineligible for intensive chemotherapy. Annals of Hematology. 95(7). 1051–1057. 13 indexed citations
8.
9.
Gu, Weiying, Lili Xiang, Guanghua Luo, et al.. (2015). Changes of Apolipoprotein M Gene Expression During the Cell Differentiation and Apoptosis Induced by Simvastatin in Combination with All-Trans Retinoic Acid in Human Promyelocytic Leukemia Cell Line NB4. Indian Journal of Hematology and Blood Transfusion. 32(1). 54–61. 1 indexed citations
10.
Xie, Xiaobao, Rong Wang, Biao Wang, et al.. (2015). Serum level of miR-10-5p as a prognostic biomarker for acute myeloid leukemia. International Journal of Hematology. 102(3). 296–303. 40 indexed citations
12.
Dong, Weimin, Xiang-shan Cao, Biao Wang, et al.. (2014). Allogeneic Hemopietic Stem Cell Transplants for the Treatment of B Cell Acute Lymphocytic Leukemia. Asian Pacific Journal of Cancer Prevention. 15(15). 6127–6130. 1 indexed citations
14.
Hu, Shaoyan, et al.. (2013). Clinical characteristics of acute promyelocytic leukemia manifesting as early death. Molecular and Clinical Oncology. 1(5). 908–910. 10 indexed citations
15.
Xiang, Lili, Man Li, Yan Liu, et al.. (2013). The clinical characteristics and prognostic significance of MN1 gene and MN1-associated microRNA expression in adult patients with de novo acute myeloid leukemia. Annals of Hematology. 92(8). 1063–1069. 25 indexed citations
16.
Zhi, Feng, Xiang-shan Cao, Xiaobao Xie, et al.. (2013). Identification of Circulating MicroRNAs as Potential Biomarkers for Detecting Acute Myeloid Leukemia. PLoS ONE. 8(2). e56718–e56718. 115 indexed citations
17.
Hu, Shaoyan, Ruihua Chen, Xing Feng, et al.. (2011). Function and Expression of Insulin-Like Growth Factor–Binding Protein 7 (IGFBP7) Gene in Childhood Acute Myeloid Leukemia. Pediatric Hematology and Oncology. 28(4). 279–287. 13 indexed citations
18.
Gu, Weiying, Xiang-shan Cao, Guoqiang Qiu, et al.. (2005). [Immunotherapy for leukemia cells by using cytotoxic T lymphocyte specifically against WT1-derived peptide: an experimental study in vitro].. PubMed. 85(49). 3475–80. 1 indexed citations
19.
Zhao, Ye, Zixing Chen, Shaoyan Hu, Jiannong Cen, & Weiying Gu. (2005). [Study on DNA methylation status of WT1 gene in its promoter region in hematologic malignancy cell lines].. PubMed. 26(9). 517–20. 1 indexed citations
20.
Bereshchenko, Oxana, Weiying Gu, & Riccardo Dalla Favera. (2002). Acetylation Inactivates the BCL6 Transcriptional Repressor. Blood. 100(11). 51316. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026